Does long-acting nanoformulated antiretroviral therapy elicit potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice?
Long-acting nanoART has translational potential with sustained and targeted efficacy and with limited systemic toxicities. Such success in drug delivery and distribution could improve drug adherence and reduce viral resistance in infected people.
Age, high body mass index, diabetes mellitus and glucose intolerance are the risk factors for developing GSD in Taiwan.